Paper33552829
MiR-192-5p regulates the proliferation and apoptosis of cholangiocarcinoma cells by activating MEK/ERK pathway.
Tang C and 8 others. 3 Biotech, 2021. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. MiR-192-5p regulates the proliferation and apoptosis of cholangiocarcinoma cells by activating MEK/ERK pathway. Papers, record 33552829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33552829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MiR-192-5p regulates the proliferation and apoptosis of cholangiocarcinoma cells by activating MEK/ERK pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24581682 | Cholangiocarcinoma. | Lancet | 2014 | https://conductscience.org/library/papers/24581682 | PubMed |
| 2 | 30251463 | Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances. | Hepatology | 2019 | https://conductscience.org/library/papers/30251463 | PubMed |
| 3 | 23276796 | RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis. | Carcinogenesis | 2013 | https://conductscience.org/library/papers/23276796 | PubMed |
| 4 | 32280242 | LncRNA FTX Contributes to the Progression of Colorectal Cancer Through Regulating miR-192-5p/EIF5A2 Axis. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32280242 | PubMed |
| 5 | 28994423 | Cholangiocarcinoma - evolving concepts and therapeutic strategies. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/28994423 | PubMed |
| 6 | 31180332 | MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/31180332 | PubMed |
| 7 | 30850362 | MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer. | Cancer Genomics Proteomics | 2019 | https://conductscience.org/library/papers/30850362 | PubMed |
| 8 | 28465351 | An HNF4α-microRNA-194/192 signaling axis maintains hepatic cell function. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28465351 | PubMed |
| 9 | 24140396 | Pathogenesis, diagnosis, and management of cholangiocarcinoma. | Gastroenterology | 2013 | https://conductscience.org/library/papers/24140396 | PubMed |
| 10 | 23948699 | Targeting MicroRNAs for personalized cancer therapy. | Med Princ Pract | 2013 | https://conductscience.org/library/papers/23948699 | PubMed |
| 11 | 30653586 | Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma. | PLoS One | 2019 | https://conductscience.org/library/papers/30653586 | PubMed |
| 12 | 24968698 | Genomic characterization of acute leukemias. | Med Princ Pract | 2014 | https://conductscience.org/library/papers/24968698 | PubMed |
| 13 | 28598255 | The regulatory role of miRNAs on VDR in breast cancer. | Transcription | 2017 | https://conductscience.org/library/papers/28598255 | PubMed |
| 14 | 27212195 | miRNA-223 inhibits epithelial-mesenchymal transition in gastric carcinoma cells via Sp1. | Int J Oncol | 2016 | https://conductscience.org/library/papers/27212195 | PubMed |
| 15 | 33061591 | CircRNA CDR1as/miR-1287/Raf1 Axis Modulates Hepatocellular Carcinoma Progression Through MEK/ERK Pathway. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33061591 | PubMed |
| 16 | 26064276 | Study on the molecular regulatory mechanism of MicroRNA-195 in the invasion and metastasis of colorectal carcinoma. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26064276 | PubMed |
| 17 | 29749758 | The role of miR-92b in cholangiocarcinoma patients. | Int J Biol Markers | 2018 | https://conductscience.org/library/papers/29749758 | PubMed |
| 18 | 12884914 | Role of MAP kinase in tumor progression and invasion. | Cancer Metastasis Rev | 2003 | https://conductscience.org/library/papers/12884914 | PubMed |
| 19 | 29571988 | MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma. | Lung Cancer | 2018 | https://conductscience.org/library/papers/29571988 | PubMed |
| 20 | 30805558 | microRNA-1236-3p Regulates DDP Resistance in Lung Cancer Cells. | Open Med (Wars) | 2018 | https://conductscience.org/library/papers/30805558 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41683945 | Exploring the Role of Extracellular Vesicles in Pancreatic and Hepatobiliary Cancers: Advances Through Artificial Intelligence. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683945 | PubMed |
| 40723336 | ERK1/2 Signaling in Intrahepatic Cholangiocarcinoma: From Preclinical Advances to Therapeutic Strategies. | Biology (Basel) | 2025 | https://conductscience.org/library/papers/40723336 | PubMed |
| 40087755 | Molecular mechanisms of miR-192 in cancer: a biomarker and therapeutic target. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40087755 | PubMed |
| 38105269 | Overexpression of microRNA-205-5p promotes cholangiocarcinoma growth by reducing expression of homeodomain-interacting protein kinase 3. | Sci Rep | 2023 | https://conductscience.org/library/papers/38105269 | PubMed |
| 36053263 | Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication <em>in vitro</em> by reinforcing miR-192-5p/ATG7-induced autophagy. | Eur J Histochem | 2022 | https://conductscience.org/library/papers/36053263 | PubMed |
| 35836925 | MiR-192-5p Alleviated Fibrosis and Inflammatory Responses of Tendon Cells by Targeting NFAT5. | Comput Math Methods Med | 2022 | https://conductscience.org/library/papers/35836925 | PubMed |
| 34953057 | MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway. | Thorac Cancer | 2022 | https://conductscience.org/library/papers/34953057 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DNTT | 1791 | PubTator's text mining | https://conductscience.org/library/genes/1791 | NCBI Gene |
| MAP2K7 | 5609 | PubTator's text mining | https://conductscience.org/library/genes/5609 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33552829
GET https://conductscience.org/api/papers/v1/33552829/references?page=2